4.7 Article

Susceptibility of OXA-48-producing Enterobacterales to imipenem/relebactam, meropenem/vaborbactam and ceftazidime/avibactam

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Microbiology

To Be or Not to Be an OXA-48 Carbapenemase

Laura Dabos et al.

Summary: Since the first description of OXA-48, more than forty variants have been recovered from Enterobacterales isolates. Some OXA-48-related enzymes exhibit similar resistance patterns, while others have reduced or marginal hydrolysis activity against certain antibiotics. Establishing hydrolytic cutoffs is urgent in determining the classification of an OXA-48-like enzyme as a carbapenemase or not.

MICROORGANISMS (2022)

Article Infectious Diseases

ResFinder 4.0 for predictions of phenotypes from genotypes

Valeria Bortolaia et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)

Review Microbiology

New beta-Lactam-beta-Lactamase Inhibitor Combinations

Dafna Yahav et al.

CLINICAL MICROBIOLOGY REVIEWS (2020)

Article Infectious Diseases

Trends in carbapenemase-producing Enterobacteriaceae, France, 2012 to 2014

L. Dortet et al.

EUROSURVEILLANCE (2017)

Review Infectious Diseases

OXA-48-like carbapenemases: the phantom menace

Laurent Poirel et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)

Article Microbiology

OXA-163, an OXA-48-Related Class D β-Lactamase with Extended Activity Toward Expanded-Spectrum Cephalosporins

Laurent Poirel et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)

Article Microbiology

Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae

L Poirel et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)